Cleveland Heartlab- BG Medicine Inc. Announce Availability of Galectin-3 Testing Through Cleveland HeartLab
10/27/2011
WALTHAM, Mass., Oct 27, 2011 (GlobeNewswire via COMTEX) -- BG Medicine, Inc., a company focused on the development and commercialization of novel, biomarker-based diagnostics, announced today that Cleveland HeartLab, Inc. is now offering BGM Galectin-3(TM) testing services.
For the complete story click here.